fingolimod hydrochloride has been researched along with Headache in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnold, DL; Banwell, B; Bar-Or, A; Brück, W; Chen, Y; Chitnis, T; Gärtner, J; Ghezzi, A; Giovannoni, G; Greenberg, B; Krupp, L; Merschhemke, M; Putzki, N; Rostásy, K; Stites, T; Tardieu, M; Waubant, E; Wolinsky, JS | 1 |
Adoni, T; Fragoso, YD; Gomes, S; Goncalves, MV; Matta, AP; Mendes, MF; Siquineli, F | 1 |
Brescia Morra, V; Brogi, D; Comi, G; Guidi, L; Laroni, A; Lugaresi, A; Mancardi, GL; Pozzilli, C; Raimondi, D; Turrini, R; Uccelli, A | 1 |
Bermel, RA; Cohen, JA; Hara-Cleaver, C; Ontaneda, D; Rudick, RA | 1 |
1 review(s) available for fingolimod hydrochloride and Headache
Article | Year |
---|---|
Oral fingolimod (gilenya) for multiple sclerosis.
Topics: Administration, Oral; Animals; Fingolimod Hydrochloride; Headache; Humans; Immunosuppressive Agents; Multiple Sclerosis; Propylene Glycols; Randomized Controlled Trials as Topic; Sphingosine | 2010 |
2 trial(s) available for fingolimod hydrochloride and Headache
Article | Year |
---|---|
Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.
Topics: Administration, Oral; Adolescent; Brain; Child; Female; Fingolimod Hydrochloride; Headache; Humans; Immunologic Factors; Infections; Injections, Intramuscular; Interferon-beta; Leukopenia; Magnetic Resonance Imaging; Male; Multiple Sclerosis, Relapsing-Remitting; Secondary Prevention | 2018 |
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy.
Topics: Adult; Female; Fingolimod Hydrochloride; Headache; Humans; Immunosuppressive Agents; Infections; Italy; Macular Edema; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Treatment Outcome | 2017 |
2 other study(ies) available for fingolimod hydrochloride and Headache
Article | Year |
---|---|
Persistent headache in patients with multiple sclerosis starting treatment with fingolimod.
Topics: Adult; Female; Fingolimod Hydrochloride; Headache; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis; Time Factors; Treatment Outcome; Young Adult | 2015 |
Early tolerability and safety of fingolimod in clinical practice.
Topics: Adult; Bradycardia; Chest Pain; Drug Substitution; Female; Fingolimod Hydrochloride; Headache; Humans; Hypertension; Lymphopenia; Macular Edema; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Nausea; Patient Acceptance of Health Care; Product Surveillance, Postmarketing; Propylene Glycols; Retrospective Studies; Sphingosine | 2012 |